Fund shareholders of Nektar Therapeutics
ISIN US6402683063 · United States · LEI 5299005I24806IOIYE03
- Fund shareholders
- 143
- Of which ETFs
- 27 116 other funds
- Value held
- 558.7M $
- Share of capital
- 24.1 % of 34.1M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 2,273 | 158.7K $ | 0.03 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 2,012 | 142.2K $ | 0.01 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Allspring Disciplined Small Cap Fund ALLSPRING FUNDS TRUST | 2,001 | 139.7K $ | 0.08 % | 0.01 % | as of Jun 30, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 1,887 | 122.4K $ | 0.02 % | 0.01 % | as of May 31, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1,617 | 114.3K $ | 1.33 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 1,487 | 103.8K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell Investments U.S. Small Cap Equity ETF Russell Investments Exchange Traded Funds | 1,450 | 101.2K $ | 0.13 % | 0.00 % | as of Jun 30, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 1,294 | 91.4K $ | 0.03 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 1,223 | 85.4K $ | 0.33 % | 0.00 % | as of Jun 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,208 | 84.3K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,000 | 69.8K $ | 0.08 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 989 | 69.9K $ | 0.08 % | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 870 | 60.7K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| FlexShares Morningstar US Market Factor Tilt Index Fund FlexShares Trust | 810 | 57.2K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 723 | 51.1K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 717 | 50.1K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 683 | 47.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 656 | 45.8K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| 1290 VT Small Cap Value Portfolio EQ Advisors Trust | 574 | 40.1K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 463 | 32.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Motley Fool Next Index ETF RBB Fund, Inc. | 455 | 29.5K $ | 0.09 % | 0.00 % | as of May 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 444 | 31.4K $ | 0.05 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 443 | 30.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 348 | 24.3K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 329 | 23K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 266 | 18.8K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Virtus AlphaSimplex Global Alternatives Fund Virtus Alternative Solutions Trust | 261 | 18.2K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 205 | 14.5K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 193 | 13.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 190 | 13.4K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 185 | 12.9K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 160 | 11.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 142 | 9.9K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 136 | 9.6K $ | 0.09 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 127 | 8.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 92 | 6.4K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 87 | 6.1K $ | 0.03 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 85 | 5.9K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 56 | 3.9K $ | 0.11 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 51 | 3.6K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 29 | 2K $ | 0.03 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 21 | 1.4K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 10 | 698.1 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 3.14 % | as of May 31, 2026 ↗ |
| Global Endurance Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 2.41 % | as of Jun 30, 2026 ↗ |
| F/m Emerald Special Situations ETF RBB Fund, Inc. | 2.05 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.88 % | as of Jun 30, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.82 % | as of Jun 30, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.42 % | as of Jul 31, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1.33 % | as of Jul 31, 2026 ↗ |
| Lord Abbett Micro-Cap Growth Fund LORD ABBETT SECURITIES TRUST | 1.12 % | as of Jul 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.80 % | as of Jul 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.67 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 143 | +60 | 8,228,998 | +56.9 % |
| 2026Q2 | 83 | +14 | 5,244,530 | +105.0 % |
| 2026Q1 | 69 | +8 | 2,558,658 | +20.1 % |
| 2025Q4 | 61 | -2 | 2,131,256 | +37.1 % |
| 2025Q3 | 63 | 1,554,732 |
Institutional managers
198 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 4,303,188 | 309.6M $ | as of Mar 31, 2026 |
| BVF INC/IL | 2,559,595 | 184.2M $ | as of Mar 31, 2026 |
| Two Seas Capital LP | 1,959,178 | 141M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 930,741 | 67M $ | as of Mar 31, 2026 |
| Prosight Management, LP | 735,000 | 52.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 692,650 | 49.8M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 659,387 | 47.4M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 578,000 | 41.6M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 567,458 | 40.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 513,531 | 36.9M $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 509,546 | 36.7M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 415,335 | 29.9M $ | as of Mar 31, 2026 |
| LORD, ABBETT & CO. LLC | 405,080 | 29.1K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 404,277 | 29.1M $ | as of Mar 31, 2026 |
| EMERALD ADVISERS, LLC | 394,604 | 28.4M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 390,675 | 28.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 346,795 | 25M $ | as of Mar 31, 2026 |
| UBS Group AG | 320,172 | 23M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 316,453 | 22.8M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 285,000 | 20.5M $ | as of Mar 31, 2026 |
| 22NW, LP | 281,115 | 20.2M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 279,150 | 20.1M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 275,000 | 19.8M $ | as of Mar 31, 2026 |
| GILDER GAGNON HOWE & CO LLC | 271,758 | 19.6M $ | as of Mar 31, 2026 |
| Nearwater Capital Markets, Ltd | 261,500 | 18.8M $ | as of Mar 31, 2026 |
Declared shareholders of Nektar Therapeutics
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Two Seas Capital LP and 2 others | 9.80 % | 3,345,978 | as of Sep 25, 2026 · SCHEDULE 13G |
| BlackRock, Inc. | 7.80 % | 2,643,796 | as of Jun 30, 2026 · SCHEDULE 13G |
| BIOTECHNOLOGY VALUE FUND L P and 9 others | 7.10 % | 2,391,075 | as of Jun 30, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.17 % | 1,747,653 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Nektar Therapeutics". https://titelia.com/en/stocks/nektar-therapeutics-US6402683063